153 related articles for article (PubMed ID: 32711584)
1. LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation.
Cui K; Zhu G
J Ovarian Res; 2020 Jul; 13(1):84. PubMed ID: 32711584
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration.
Wang QA; Yang Y; Liang X
J Ovarian Res; 2020 Apr; 13(1):37. PubMed ID: 32293505
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CTBP1-AS2 Promotes Cell Proliferation in Hepatocellular Carcinoma by Regulating the miR-623/Cyclin D1 Axis.
Wang M; Zhao H
Cancer Biother Radiopharm; 2020 Dec; 35(10):765-770. PubMed ID: 32522013
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
Sun T; Yang P; Gao Y
Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation.
Zhang H; Li J; Shao W; Shen N
Clin Rheumatol; 2020 Nov; 39(11):3473-3478. PubMed ID: 32388751
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
9. CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis.
Yang G; Zhang C
Environ Sci Pollut Res Int; 2022 May; 29(25):38385-38394. PubMed ID: 35076836
[TBL] [Abstract][Full Text] [Related]
10. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
Li Y; Zong J; Zhao C
Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
[TBL] [Abstract][Full Text] [Related]
11. STAT3 regulated
Jin P; Liu Y; Wang R
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30061175
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis.
Wang G; Wu B; Zhang B; Wang K; Wang H
Biochem Biophys Res Commun; 2020 Nov; 532(2):308-314. PubMed ID: 32868076
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
14. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
15. CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis.
Li R; Liu Y; Liu J; Chen B; Ji Z; Xu A; Zhang T
Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):385-394. PubMed ID: 38622049
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway.
Gong J; Xu X; Zhang X; Zhou Y
Aging (Albany NY); 2020 Jul; 12(14):14314-14328. PubMed ID: 32675386
[TBL] [Abstract][Full Text] [Related]
17. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p.
Liu LX; Liu B; Yu J; Zhang DY; Shi JH; Liang P
Biochem Biophys Res Commun; 2020 Dec; 533(4):779-785. PubMed ID: 32988587
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes.
Erfanian Omidvar M; Ghaedi H; Kazerouni F; Kalbasi S; Shanaki M; Miraalamy G; Zare A; Rahimipour A
J Cell Biochem; 2019 Jun; 120(6):9315-9323. PubMed ID: 30506719
[TBL] [Abstract][Full Text] [Related]
19. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells.
Zhong Y; Li Y; Song T; Zhang D
Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
